New analysis method for predicting the risks and effects of immunotherapy
In a new study, researchers at Uppsala University, Sweden, have been able to show differences…
Browsing: Rituximab
Phase III results show rituximab excels against paediatric Burkitt lymphoma
Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported in the New England Journal of…
The fight goes on: Clinical trial shows promising new treatment for rare blood cancer
Lymphoma is a type of blood cancer that develops from lymphocytes (a type of white…
Drug combo heralds major shift in chronic lymphocytic leukaemia treatment
A combination of two drugs keeps patients with chronic lymphocytic leukaemia disease-free and alive longer…